Holdings
Sr One Capital Management, LP
As of Sep 30, 2026, Sr One Capital Management, LP reported 13 positions worth US$1.01B. Largest: Veradermics, Incorporated, ADARx Pharmaceuticals, Inc. and Zenas BioPharma, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Veradermics, Incorporated | 2.08M | US$252M | −322K | Sep 30, 2026 |
| ADARx Pharmaceuticals, Inc. | 9.94M | US$198M | new | Sep 30, 2026 |
| Zenas BioPharma, Inc. | 5.04M | US$136M | no change | Sep 30, 2026 |
| Avalyn Pharma Inc. | 3.31M | US$94.3M | no change | Sep 30, 2026 |
| Odyssey Therapeutics, Inc. | 3.79M | US$84.3M | no change | Sep 30, 2026 |
| Design Therapeutics, Inc. | 6.53M | US$82M | no change | Sep 30, 2026 |
| ORIC Pharmaceuticals, Inc. | 4.62M | US$62.2M | no change | Sep 30, 2026 |
| Mineralys Therapeutics, Inc. | 1.56M | US$39.3M | no change | Sep 30, 2026 |
| Mobia Medical, Inc. | 1.99M | US$18.8M | no change | Sep 30, 2026 |
| ARS Pharmaceuticals, Inc. | 4.01M | US$17.3M | no change | Sep 30, 2026 |